Bridging Radiation Rapidly and Effectively Cytoreduces High Risk Relapsed/Refractory Aggressive B-Cell Lymphomas Prior to Chimeric Antigen Receptor T-Cell Therapy. uri icon

authors

  • Hubbeling, Harper
  • Batlevi, Connie
  • Dahi, Parastoo
  • Giralt, Sergio
  • Richard J Lin, MD, PhD
  • Park, Jae
  • Scordo, Michael
  • Sauter, Craig
  • Shah, Gunjan
  • Hajj, Carla
  • Salles, Gilles
  • Silverman, Emily A
  • Schoder, Heiko
  • Palomba, M Lia
  • Perales, Miguel-Angel
  • Yahalom, Joachim
  • Imber, Brandon S
  • Michaud, Laure
  • Tomas, Ana Alarcon
  • Shouval, Roni
  • Flynn, Jessica
  • Devlin, Sean
  • Wijetunga, N Ari
  • Tringale, Kathryn R

publication date

  • January 1, 2022